# Hims & Hers Health (NYSE:HIMS) rises as FDA BPC-157 decision turns market attention to revenue per subscriber - TechStock²

*Источник: TechStock²*
*Дата: 2026-07-23*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPMHJ0eHlaNFczWVhjV0NrbVRRSm5aYTN6WUQzT281dHY4Y3p0WWdNc0RuRlBlSUhMYTA4NE1xMzJrQ1BWcjRTS3RTemRfVGNEN2lVUEZPVkdzTDNNSTVJU0twMk5kTG1Id0VBUHFNSS1mWFhzYWVjWFpSTzlGSXp1eERCTW5xcUFjV0JjaGl1Q1ltcmNkMmxhSlQwVUc2LTdUR2lSOUIxQ1dxZnVhZm82WGtTZ0RibGdWUHBucXlMTFEtTDQ?oc=5" target="_blank">Hims & Hers Health (NYSE:HIMS) rises as FDA BPC-157 decision turns market attention to revenue per subscriber</a>&nbsp;&nbsp;<font color="#6f6f6f">TechStock²</font>

[Оригинал](https://ts2.tech/en/hims-hers-health-nysehims-rises-as-fda-bpc-157-decision-turns-market-attention-to-revenue-per-subscriber/)